Étiquette : psychedelics

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics, R. L. Carhart-Harris and K. J. Friston, 2019

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics R. L. Carhart-Harris and K. J. Friston Pharmacological Reviews, 2019,  71, 316–344 https://doi.org/10.1124/pr.118.017160   Significance Statement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . . . . . . . . . . . . . . 317 I. Introduction. . . . . . . . . . . . . . . . . . . . . . . . .  [...]

Lire la suite

Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives, Carla Pallavicini et al., 2019

Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives Carla Pallavicini, Martina G. Vilas, Mirta Villarreal, Federico Zamberlan, Suresh Muthukumaraswamy, David Nutt, Robin Carhart-Harris, Enzo Tagliazucchi NeuroImage, 2019 https://doi.org/10.1016/j.neuroimage.2019.06.053 Abstract Classic serotonergic psychedelics are remarkable for their capacity to induce reversible alterations in consciousness of the self and the surroundings, mediated by agonism at serotonin 5-HT2A receptors. The subjective effects elicited by dissociative drugs acting as N-methyl-D-aspartate (NMDA) antagonists (e.g. ketamine and phencyclidine) overlap in certain domains with those of serotonergic psychedelics, suggesting some potential similarities in the brain activity patterns induced by both classes of drugs, despite different pharmacological mechanisms of action. We investigated source-localized [...]

Lire la suite

Prevalence and epidemiological associates of novel psychedelic use in the United States adult population, James D Sexton et al., 2019

Prevalence and epidemiological associates of novel psychedelic use in the United States adult population James D. Sexton, Michael S. Crawford, Noah W. Sweat, Allyson Varley , Emma E. Green and Peter S. Hendricks Journal of Psychopharmacology, 1-10 DOI : 10.1177/0269881119827796 journals.sagepub.com/home/jopract Abstract Background : Novel psychedelics approximate classic psychedelics, but unlike classic psychedelics, novel psychedelics have been used by humans for a shorter period of time, with fewer data available on these substances. Aims : The purpose of this study was to determine the prevalence of novel psychedelic use and the associations of novel psychedelic use with mental health outcomes. Methods : We estimated the prevalence of self-reported, [...]

Lire la suite

Disruptive Psychopharmacology, Jama Psychiatry, June 2019

Disruptive Psychopharmacology Boris D. Heifets, MD, PhD1; Robert C. Malenka, MD, PhD2 JAMA Psychiatry. Published online June 26, 2019. doi:10.1001/jamapsychiatry.2019.1145 The paucity of medications with novel mechanisms for the treatment of mental illnesses combined with the delayed response to currently available medications has led to great excitement about the potential therapeutic utility of previously demonized drugs, which offer the hope of generating rapid symptom reductions in some of the sickest patients. Within the past 2 years, the US Food and Drug Administration approved esketamine for treatment-resistant depression and 2 compounds that are still on the US Drug Enforcement Administration’s most restrictive schedule, 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin, [...]

Lire la suite

Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice, Adam L. Halberstadt et al., 2019

Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice Adam L. Halberstadt, Muhammad Chatha, Stephen J. Chapman and Simon D. Brandt Journal of Psychopharmacology, 2019, 1 –9 DOI: 10.1177/0269881119826610 journals.sagepub.com/home/jop Abstract Background : In recent years, there has been increasing scientific interest in the effects and pharmacology of serotonergic hallucinogens. While a large amount of experimental work has been conducted to characterize the behavioral response to hallucinogens in rodents, there has been little systematic investigation of mescaline and its analogs. The hallucinogenic potency of mescaline is increased by α-methylation and by homologation of the 4-methoxy group but it not clear [...]

Lire la suite

Analysis of adulterants in prepared bhang from different Authorized bhang shops, Shrawan Kumar Sadawarti et al., 2018

Analysis of adulterants in prepared bhang from different Authorized bhang shops Shrawan Kumar Sadawarti, Lav Kesharwani, A. K. Jain, Vaibhav Saran, A. K. Gupta Academic Journal of Forensic Sciences, Volume 01 | Issue 02 | October-2018 Available online at : www.xournals.com   Abstract : Cannabis is a tall, erect, annual, dioecious herb, provided with an open sunny environment, light, well-drained composted soil and ample irrigation. Bhang is obtained from cut tops of uncultivated plants and is least potent. The potency depends upon the concentration of Tetrahydrocannabinol (THC). It is a narcotic drug and is analgesic in nature. Bhang is prepared by crushing the leaf of cannabis [...]

Lire la suite

Discriminative Stimulus Effects of Psychostimulants and Hallucinogens in S()-3,4-Methylenedioxymethamphetamine (MDMA) and R()-MDMA Trained Mice, K. S. Murnane, 2009

Discriminative Stimulus Effects of Psychostimulants and Hallucinogens in S()-3,4-Methylene-dioxy-meth amphetamine (MDMA) and R()-MDMA Trained Mice K. S. Murnane, N. Murai, L. L. Howell, and W. E. Fantegrossi THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, Vol. 331, No. 2 Copyright © 2009 by The American Society for Pharmacology and Experimental Therapeutics 156174/3525473 JPET 331:717–723, 2009 Preliminary findings from these experiments were previously presented as follows : Murnane K.S., 2008 Expérimentalement Biology Meeting; San Diego, CA. doi:10.1124/jpet.109.156174. ABSTRACT 3,4-Methylenedioxymethamphetamine (MDMA) is a substituted phenethylamine more commonly known as the drug of abuse “ecstasy.” The acute and persistent neurochemical effects of MDMA in the mice are distinct from those in [...]

Lire la suite

Dream over life : Psychedelic terphenyl derivative induce hallucination via cannabinoid receptor 1, F.A. Fauzi et al., 2018

Dream over life : Psychedelic terphenyl derivative induce hallucination via cannabinoid receptor 1 F.A. Fauzi, M.S. Goh, S.A.T.T. Johari, F. Hashim, M.F.N. Hassim The International Fundamentum Sciences Symposium 2018 IOP Publishing IOP Conf. Series: Materials Science and Engineering 440 (2018) 012045 doi:10.1088/1757-899X/440/1/012045   Abstract. For ages, natural psychedelic resources have been used by ancient tribes for religious inspiration. In modern medicine, these compounds were prescribed to relieve severe distress and depression on cancer patients. Despite medical benefit, abuse of these compounds have become prevalent in our modern society. These compounds usually interacted withcannabinoid receptor 1 (CNR1) on neuron cell causing hallucination, and on other cell-types. In this [...]

Lire la suite

Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin, Louis-David Lord, David J. Nutt, Robin L. Carhart-Harris et al., 2019

Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin Louis-David Lord, Paul Expert, Selen Atasoy, Leor Roseman, Kristina Rapuano, Renaud Lambiotte, David J. Nutt, Gustavo Deco, Robin L. Carhart-Harris, Morten L. Kringelbach, Joana Cabral, NeuroImage, 2019, 199, 127–142 https://doi.org/10.1016/j.neuroimage.2019.05.060 A B S T R A C T Growing evidence from the dynamical analysis of functional neuroimaging data suggests that brain function can be understood as the exploration of a repertoire of metastable connectivity patterns (‘functional brain networks’), which potentially underlie different mental processes. The present study characterizes how the brain's dynamical exploration of resting-state networks is rapidly modulated by intravenous [...]

Lire la suite

The World Ayahuasca Diaspora. Reinventions and controversies, Forword. Ayahuasca in the twenty-first century : having it both ways, Glenn H. Shepard Jr., 2017

The World Ayahuasca Diaspora. Reinventions and controversies Forword. Ayahuasca in the twenty-first century : having it both ways Glenn H. Shepard Jr. Museu Paraense Emílio Goeldi Edited by Beatriz Caiuby Labate, Clancy Cavnar, and Alex K. Gearin janvier 2017   The genie is out of the bottle, tweeting about the next shamanic bodywork leadership seminar, and the bottle; well, check and see if it isn’t in the back of your fridge by the vegan TV dinner. Who would have ever imagined that ayahuasca, the enigmatic jungle potion William S. Burroughs once referred to as “the secret” (Burroughs & Ginsberg, 2006 [1963]) and whose very botanical identity was a matter [...]

Lire la suite